Exagen Investor Relations Material

Exagen Inc. is a biotechnology company that develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. The company's AVISE HemaVision tests are used to detect blood clots and other vascular conditions such as arterial plaques. Its AVISE OncoVision tests are clinically validated immunoassay products indicated for the detection of prostate cancer and other solid tumor antigens, as well as for facilitating primary care physicians’ early detection of cancer.